CN109187146A - 人体细胞全形态免疫荧光染色方法及试剂盒 - Google Patents
人体细胞全形态免疫荧光染色方法及试剂盒 Download PDFInfo
- Publication number
- CN109187146A CN109187146A CN201810978362.6A CN201810978362A CN109187146A CN 109187146 A CN109187146 A CN 109187146A CN 201810978362 A CN201810978362 A CN 201810978362A CN 109187146 A CN109187146 A CN 109187146A
- Authority
- CN
- China
- Prior art keywords
- cell
- marker
- antibody
- liquid
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004043 dyeing Methods 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000010166 immunofluorescence Methods 0.000 title claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims abstract description 167
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 40
- 239000003550 marker Substances 0.000 claims description 80
- 239000007788 liquid Substances 0.000 claims description 60
- 210000004940 nucleus Anatomy 0.000 claims description 47
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- 239000007850 fluorescent dye Substances 0.000 claims description 41
- 238000004140 cleaning Methods 0.000 claims description 35
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 32
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 32
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 32
- 239000000243 solution Substances 0.000 claims description 32
- 239000012295 chemical reaction liquid Substances 0.000 claims description 26
- 238000001514 detection method Methods 0.000 claims description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 23
- 210000000633 nuclear envelope Anatomy 0.000 claims description 23
- 244000309466 calf Species 0.000 claims description 21
- 210000002966 serum Anatomy 0.000 claims description 21
- 239000012895 dilution Substances 0.000 claims description 18
- 238000010790 dilution Methods 0.000 claims description 18
- 230000000149 penetrating effect Effects 0.000 claims description 18
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical group C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 17
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims description 17
- 238000005406 washing Methods 0.000 claims description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 238000010186 staining Methods 0.000 claims description 10
- 239000000975 dye Substances 0.000 claims description 6
- 238000007447 staining method Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 239000002791 cell membrane marker Substances 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 229920006324 polyoxymethylene Polymers 0.000 claims 1
- 239000000427 antigen Substances 0.000 abstract description 22
- 102000036639 antigens Human genes 0.000 abstract description 22
- 108091007433 antigens Proteins 0.000 abstract description 22
- 210000000805 cytoplasm Anatomy 0.000 abstract description 6
- 238000004458 analytical method Methods 0.000 abstract description 4
- 238000003125 immunofluorescent labeling Methods 0.000 abstract description 3
- 102000019040 Nuclear Antigens Human genes 0.000 abstract 1
- 108010051791 Nuclear Antigens Proteins 0.000 abstract 1
- 230000000877 morphologic effect Effects 0.000 abstract 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 12
- 102100021010 Nucleolin Human genes 0.000 description 11
- 102000005525 fibrillarin Human genes 0.000 description 11
- 108020002231 fibrillarin Proteins 0.000 description 11
- 108010044762 nucleolin Proteins 0.000 description 11
- 229930040373 Paraformaldehyde Natural products 0.000 description 9
- 229920002866 paraformaldehyde Polymers 0.000 description 9
- 230000003211 malignant effect Effects 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- 241000283074 Equus asinus Species 0.000 description 7
- 102000007562 Serum Albumin Human genes 0.000 description 7
- 108010071390 Serum Albumin Proteins 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000007170 pathology Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004624 confocal microscopy Methods 0.000 description 5
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 3
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 3
- 108010091675 Cellular Apoptosis Susceptibility Protein Proteins 0.000 description 2
- 102100029091 Exportin-2 Human genes 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
- 102000013127 Vimentin Human genes 0.000 description 2
- 108010065472 Vimentin Proteins 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000001744 histochemical effect Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000009595 pap smear Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000012128 staining reagent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000005048 vimentin Anatomy 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 1
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 1
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710200609 Nucleolin 1 Proteins 0.000 description 1
- 102100022678 Nucleophosmin Human genes 0.000 description 1
- 108010025568 Nucleophosmin Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000003887 myelocyte Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/302—Stain compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810978362.6A CN109187146B (zh) | 2018-08-27 | 2018-08-27 | 人体细胞全形态免疫荧光染色方法及试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810978362.6A CN109187146B (zh) | 2018-08-27 | 2018-08-27 | 人体细胞全形态免疫荧光染色方法及试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109187146A true CN109187146A (zh) | 2019-01-11 |
CN109187146B CN109187146B (zh) | 2021-03-30 |
Family
ID=64916021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810978362.6A Active CN109187146B (zh) | 2018-08-27 | 2018-08-27 | 人体细胞全形态免疫荧光染色方法及试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109187146B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110161227A (zh) * | 2019-05-22 | 2019-08-23 | 北京中科纳泰生物科技有限公司 | 带荧光标记的人源细胞角蛋白混合抗体及其制备方法 |
CN110596366A (zh) * | 2019-08-07 | 2019-12-20 | 四川大学华西医院 | 一种p53蛋白和线粒体双标记免疫荧光检测方法及其试剂盒 |
CN110687085A (zh) * | 2019-09-29 | 2020-01-14 | 广东工业大学 | 一种固定液和固定细胞的方法与应用 |
CN110749579A (zh) * | 2019-08-29 | 2020-02-04 | 西安医学院 | 一种通过免疫荧光检测药物对胰岛细胞摄脂影响的方法 |
CN114316967A (zh) * | 2021-12-31 | 2022-04-12 | 湖南智享未来生物科技有限公司 | 一种碳点组合物、制备方法以及在细胞核、膜共染中的应用 |
CN116754768A (zh) * | 2023-05-30 | 2023-09-15 | 中山大学附属第五医院 | Ddx24在维持内皮细胞的核仁稳态中的应用 |
CN117169093A (zh) * | 2023-10-30 | 2023-12-05 | 深圳市明鉴检测专业技术有限公司 | 基于荧光抗体标记的细胞定量检测方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103293321A (zh) * | 2013-05-27 | 2013-09-11 | 北京大学 | 一种检测dna损伤诱导的早期核仁应激的试剂盒及其应用 |
CN104931324A (zh) * | 2015-06-11 | 2015-09-23 | 宁波美晶医疗技术有限公司 | 一种循环肿瘤细胞的染色试剂盒 |
CN105717310A (zh) * | 2016-04-15 | 2016-06-29 | 肖乐义 | 一种检测白细胞中结核分枝杆菌的免疫荧光染色方法及试剂盒 |
CN107153054A (zh) * | 2017-03-16 | 2017-09-12 | 国家烟草质量监督检验中心 | 一种基于高内涵技术定量分析烟碱致细胞dna损伤的方法 |
CN108254237A (zh) * | 2017-12-12 | 2018-07-06 | 浙江海洋大学 | 一种活细胞荧光染色方法 |
-
2018
- 2018-08-27 CN CN201810978362.6A patent/CN109187146B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103293321A (zh) * | 2013-05-27 | 2013-09-11 | 北京大学 | 一种检测dna损伤诱导的早期核仁应激的试剂盒及其应用 |
CN104931324A (zh) * | 2015-06-11 | 2015-09-23 | 宁波美晶医疗技术有限公司 | 一种循环肿瘤细胞的染色试剂盒 |
CN105717310A (zh) * | 2016-04-15 | 2016-06-29 | 肖乐义 | 一种检测白细胞中结核分枝杆菌的免疫荧光染色方法及试剂盒 |
CN107153054A (zh) * | 2017-03-16 | 2017-09-12 | 国家烟草质量监督检验中心 | 一种基于高内涵技术定量分析烟碱致细胞dna损伤的方法 |
CN108254237A (zh) * | 2017-12-12 | 2018-07-06 | 浙江海洋大学 | 一种活细胞荧光染色方法 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110161227A (zh) * | 2019-05-22 | 2019-08-23 | 北京中科纳泰生物科技有限公司 | 带荧光标记的人源细胞角蛋白混合抗体及其制备方法 |
CN110596366A (zh) * | 2019-08-07 | 2019-12-20 | 四川大学华西医院 | 一种p53蛋白和线粒体双标记免疫荧光检测方法及其试剂盒 |
CN110596366B (zh) * | 2019-08-07 | 2020-06-30 | 四川大学华西医院 | 一种p53蛋白和线粒体双标记免疫荧光检测方法及其试剂盒 |
CN110749579A (zh) * | 2019-08-29 | 2020-02-04 | 西安医学院 | 一种通过免疫荧光检测药物对胰岛细胞摄脂影响的方法 |
CN110687085A (zh) * | 2019-09-29 | 2020-01-14 | 广东工业大学 | 一种固定液和固定细胞的方法与应用 |
CN114316967A (zh) * | 2021-12-31 | 2022-04-12 | 湖南智享未来生物科技有限公司 | 一种碳点组合物、制备方法以及在细胞核、膜共染中的应用 |
CN114316967B (zh) * | 2021-12-31 | 2023-04-14 | 湖南智享未来生物科技有限公司 | 一种碳点组合物、制备方法以及在细胞核、膜共染中的应用 |
CN116754768A (zh) * | 2023-05-30 | 2023-09-15 | 中山大学附属第五医院 | Ddx24在维持内皮细胞的核仁稳态中的应用 |
CN116754768B (zh) * | 2023-05-30 | 2024-03-29 | 中山大学附属第五医院 | Ddx24在维持内皮细胞的核仁稳态中的应用 |
CN117169093A (zh) * | 2023-10-30 | 2023-12-05 | 深圳市明鉴检测专业技术有限公司 | 基于荧光抗体标记的细胞定量检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109187146B (zh) | 2021-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109187146A (zh) | 人体细胞全形态免疫荧光染色方法及试剂盒 | |
CN101587043B (zh) | 从生物体液样本中富集与检测稀有细胞的整合方法 | |
CN105785005A (zh) | 一种循环肿瘤细胞的检测试剂盒及其应用 | |
EP3555622B1 (en) | Methods and systems for quantitative immunohistochemistry | |
CN101226118B (zh) | 一种兼容免疫荧光分析的细胞化学染色方法及其用途 | |
CN105143847B (zh) | 细胞染色组合物及其用途 | |
JPH01127956A (ja) | 生物標本の分析用キット | |
CN110095599B (zh) | 无细胞损失的微量免疫荧光检测方法 | |
CN110494739A (zh) | 荧光图像中靶分子密度的确定 | |
CN104094116A (zh) | 在哺乳动物个体中检测5t4阳性循环肿瘤细胞的方法和诊断5t4阳性癌症的方法 | |
CN105223361B (zh) | 一种检测急性t淋巴细胞白血病幼稚t细胞的试剂盒、应用及方法 | |
CN114127562A (zh) | 一种肿瘤细胞表面标志分子pd-l1的检测方法 | |
CN103702735B (zh) | 用于光学分析和特异性分离生物学样品的装置和方法 | |
Harris et al. | Imaging of neutral lipids and neutral lipid associated proteins | |
JPH0473104B2 (zh) | ||
CN106771185A (zh) | 一种鼻咽癌循环肿瘤细胞检测试剂盒 | |
EP3040724B1 (en) | Method for determining quantity of biological material in tissue section | |
Dellavance et al. | Detection of autoantibodies by indirect immunofluorescence cytochemistry on HEp-2 cells | |
Hussaini et al. | Immunohistochemistry and immunofluorescence | |
CN111812071A (zh) | 一种新型循环肿瘤细胞的鉴定技术 | |
CN106834511A (zh) | 一种基于液体活检的乳腺癌检测的试剂盒 | |
CN109946278A (zh) | 荧光染料dapi对细胞dna进行染色定量的癌症筛查和诊断方法 | |
RU2419798C1 (ru) | Способ иммуногистохимического окрашивания криостатных срезов тканей в условиях интраоперационной диагностики | |
JP6670503B2 (ja) | 生体由来細胞を用いたがん細胞の検出方法 | |
Soygur et al. | A roadmap for three-dimensional analysis of the intact mouse ovary |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.1 Huanghai Road, Shuiji sub district office, Laixi City, Qingdao City, Shandong Province 266600 Applicant after: Qingdao Yanding Biomedical Technology Co.,Ltd. Address before: No.1 Huanghai Road, Shuiji sub district office, Laixi City, Qingdao City, Shandong Province 266600 Applicant before: QINGDAO PEKING UNIVERSITY NEW CENTURY YANDING BIOMEDICAL TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Human cell whole morphology immunofluorescence staining method and kit Effective date of registration: 20230721 Granted publication date: 20210330 Pledgee: Weihai commercial bank Limited by Share Ltd. Qingdao branch Pledgor: Qingdao Yanding Biomedical Technology Co.,Ltd. Registration number: Y2023980049237 |